8 Targeted Protein Degradation conferences in 2023 you won’t want to miss
9 Targeted Protein Degradation conferences you don’t want to miss in 2022
10 terms to help you more easily understand targeted protein degradation
Why so many companies are betting on PROTACs as a superior therapeutic modality
Protein degraders show promising results in drug development pipelines. See progress candidates have made.
Are you building an effective protein degrader? 4 questions to ask yourself to find out
6 protein degradation conferences in 2021 you can’t afford to miss
3 case studies on how to characterize challenging drug discovery targets — membrane proteins, peptide libraries, and PROTACs
NanoTemper debuts the newly redesigned Monolith, offering higher-quality molecular interaction measurements for very challenging targets
